This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Jacquelyn N. Arcati
Associate
New York +1 212 841 1011 jarcati@cov.com Download V-card

Jacquelyn Arcati is an associate in the firm’s New York office and a member of the Corporate Practice Group. Ms. Arcati specializes in mergers and acquisitions and has experience in public and private company mergers, public company tender offers, hostile defense, unsolicited bidding, going-private transactions and asset and stock purchases and divestitures.

  • Represented Oxford Immunotec Global PLC (NASDAQ: OXFD):
    • in its acquisition of substantially all of the assets of Imugen, Inc., a clinical laboratory company focused on developing and performing specialized testing for tick-borne diseases; and
    • in its acquisition of Immunetics Inc., a diagnostics company focused on specialized infectious disease testing.
  • Represented a publicly listed pharmaceutical company:
    • in its $26 billion unsolicited offer to acquire another publicly listed pharmaceutical company; and
    • in its successful defense of a hostile tender offer.
  • Represented a publicly listed health insurance company in its proposed sale to another publicly listed health insurance company.
  • Represented a publicly listed technology company:
    • in its acquisition of a leading provider of cloud-based mobile messaging tools; and
    • in its acquisition of a company specializing in the automation of software-delivery.
  • Represented a publicly listed forest-product producer in its acquisition of a publicly listed timberland owner/manager.
  • Represented a publicly listed supplier of aggregates/building materials in its $2.7 billion acquisition of a publicly listed construction materials company.
  • Represented a publicly listed oil and gas servicer in its formation of an international joint venture with a publicly listed supplier of products to customers in the oil and gas industry.
  • Represented a publicly listed apparel company in its $2 billion going-private transaction with a leading private equity firm.
  • Represented a global chemicals company in its investment in a company engaged in the manufacture and sale of specialty chemicals, catalysts and glass materials.